In some specific examples, such as in melanoma, reduced editing efficiency has been proposed to be important in the pathogenesis of these tumours (48), although this appears to be less common than an increased expression of ADAR1 and higher overall A-to-I editing levels. The gene discussed is ADAR; the disease is neoplasm.